Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Flor Perez-Retiguin"'
Autor:
Elba Reyes-Maldonado, Abraham Majluf-Cruz, Jorge Vela-Ojeda, Miriam García-Ruiz Esparza, Ana Cristina Olivas-Bejarano, Laura Montiel-Cervantes, Flor Perez-Retiguin, Jaime García-Chávez
Publikováno v:
Leukemialymphoma. 62(4)
Previous studies demonstrated that the majority of Hodgkin lymphoma (HL) patients achieve response after treatment, while 5% become refractory. Studies analyzing the role of lymphocyte subsets in peripheral blood are limited. This investigation sough
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b750d1bf8e2e278a8a3ad934fa1fe2a8
https://pubmed.ncbi.nlm.nih.gov/33284055
https://pubmed.ncbi.nlm.nih.gov/33284055
Autor:
Abraham Majluf-Cruz, Myriam Garcia-Ruiz, Elba Reyes-Maldonado, Jaime García-Chávez, Laura Montiel-Cervantes, Ana Cristina Olivas-Bejarano, Jorge Vela Ojeda, Flor Perez-Retiguin
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S236
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ce6fd5f610138bf0e79be6d95442b70
https://doi.org/10.1016/s2152-2650(21)01486-5
https://doi.org/10.1016/s2152-2650(21)01486-5
Autor:
Ana Cristina Olivas-Bejarano, Myriam Garcia-Ruiz, Abraham Majluf-Cruz, Jaime García-Chávez, Elba Reyes-Maldonado, Laura Montiel-Cervantes, Jorge Vela Ojeda, Flor Perez-Retiguin
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S370
Context The majority of Hodgkin lymphoma (HL) patients achieve response after treatment, but 5%–10% of them become refractory. It is very important in this fraction of patients to understand the mechanisms used by malignant cells to avoid the anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b738fc966e3e2d9835e295ad31288e44
https://doi.org/10.1016/s2152-2650(21)01847-4
https://doi.org/10.1016/s2152-2650(21)01847-4
Autor:
Vela Ojeda, Jorge Vela Ojeda, Perez-Retiguin, Flor, Olivas-Bejarano, Ana Cristina, Garcia-Ruiz, Myriam, Garcia-Chavez, Jaime, Majluf-Cruz, Abraham, Reyes-Maldonado, Elba, Montiel-Cervantes, Laura
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS236-S236, 1p
Autor:
Ojeda, Jorge Vela Ojeda Vela, Perez-Retiguin, Flor, Olivas-Bejarano, Ana Cristina, Garcia-Ruiz, Myriam, Garcia-Chavez, Jaime, Majluf-Cruz, Abraham, Reyes-Maldonado, Elba, Montiel-Cervantes, Laura
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS370-S370, 1p